By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Regulus Therapeutics, Inc. 

1896 Rutherford Road

Carlsbad  California  92008-7208  U.S.A.
Phone: 888-734-8587 Fax: n/a


Start Up

Company News
Regulus (RGLS) Announces Grant Of Patents Covering Lead microRNA Therapeutics 11/12/2015 4:36:13 PM
Regulus (RGLS) Reports Third Quarter 2015 Financial Results And Recent Highlights 11/6/2015 7:19:07 AM
Regulus (RGLS) Expands Development Of RG-101 Through Clinical Trial Collaboration With GlaxoSmithKline (GSK) 11/3/2015 6:54:24 AM
Regulus (RGLS) Announces Timing For Third Quarter 2015 Financial Results Webcast And Conference Call 10/30/2015 6:33:48 AM
Regulus (RGLS) Achieves All Research Milestones In Collaboration With Biogen (BIIB) To Identify microRNA Biomarkers For Multiple Sclerosis 10/28/2015 7:42:17 AM
Regulus (RGLS) To Present Additional Preclinical Data Supporting RG-012 As A Novel microRNA Therapeutic In Development For Alport Syndrome At American Society of Nephrology's Kidney Week 2015 10/6/2015 7:03:53 AM
Regulus (RGLS) To Present Updated Data Supporting RG-101 As Novel microRNA Therapeutic For The Treatment Of HCV At The Liver Meeting 2015 (AASLD) 10/2/2015 6:12:50 AM
Regulus (RGLS) Appoints Michael Huang, M.D. As Vice President, Clinical Development 8/25/2015 6:34:31 AM
Regulus (RGLS) To Present At The 2015 Wedbush PacGrow Healthcare Conference 8/7/2015 6:42:53 AM
Regulus (RGLS) Reports Second Quarter 2015 Financial Results And Recent Highlights 8/5/2015 7:29:12 AM